Search Results

Pictured: Concept art showing a broken head figure

FDA

ICER Finds ‘Substantial Uncertainties’ in Lykos’ MDMA Trials Ahead of Adcomm

With a June 4 FDA advisory committee meeting looming, the Institute for Clinical and Economic Review has raised concerns about Lykos Therapeutics’ trials of its MDMA-assisted therapy in post-traumatic stress disorder.

May 16, 2024

·

2 min read

·

Tristan Manalac

Biotech Beach

Vasa Therapeutics Announces Closing of Seed Financing to Advance Novel Therapies for Diseases of Cardiovascular Aging

Vasa Therapeutics, Inc. announced today the closing of series seed funding led by Orphinic Scientific SA (“Orphinic”), an early-stage investor focused on companies with game-changing potential.

January 3, 2024

·

2 min read

BioMidwest

Convention-Busting Experience Life Magazine Expands National and Local Acclaim

On the heels of receiving four awards at FOLIO: in October, Experience Life, the whole-life health and fitness magazine, was awarded top honors in six categories on Thursday, November 1, at the Minnesota Media and Publishing Association (MMPA) Excellence Awards

November 21, 2018

·

2 min read

Deals

MERGER CREATES NEW GLOBAL LEADER IN BIOSPECIMEN SOLUTIONS: FOUR COMPANIES UNITE TO FORM DISCOVERY LIFE SCIENCES

Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny announced today that they have merged under the name Discovery Life Sciences™ (Discovery) to create a global market leader in biospecimen analysis and procurement for the pharmaceutical, biotechnology and diagnostics industries.

October 15, 2018

·

2 min read

Bio NC

Female-owned biotech startup, Tiamat Sciences raise an extension of $2M to accelerate product validation and strategic partnerships

Biotechnology startup Tiamat Sciences announced its $2 million seed-extension financing round led by 8090 Industries with participation from new and existing investors.

March 9, 2023

·

3 min read

Pharm Country

Amplo Biotechnology Closes Series Seed Financing to Advance Gene Therapies for The Treatment of Neuromuscular Junction Disorders

Amplo Biotechnology today announced the successful closing of an undisclosed Series Seed financing.

October 6, 2021

·

1 min read

Tissue and Organ Transplantation Market Key Players Business Strategies Study Analysis

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.

December 14, 2021

·

5 min read

Business

R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company’s board of directors, effective August 11, 2021.

August 12, 2021

·

2 min read

Tissue and Organ Transplantation Market Key Players Business Strategies Study Analysis Report

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.

June 22, 2021

·

3 min read

Tissue and Organ Transplantation Market | Expansive Coverage on the Latest Developments in the Market

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.

April 13, 2021

·

3 min read